Parameters of hepatotoxic reactions caused by the combination of first line anti-tuberculosis drugs in rats with different acetylation phenotypes
https://doi.org/10.21292/2075-1230-2020-98-7-51-55
Abstract
The objective: in the experiment, to study specific parameters of manifestations of hepatotoxic reactions to the combination of anti-tuberculosis drugs containing isoniazid and rifampicin in rats with different acetylation phenotypes.
Subjects and methods. Liver damage was modeled in rats, old females, belonging to the phenotype of rapid acetylation, and in mature males, belonging to the phenotype of slow acetylation, with a combination of basic anti-tuberculosis drugs, which were administered for 14 days. Hepatotoxic reactions were assessed by clinical observations of rats, biochemical parameters and morphological changes in the liver, which were compared with intact animals.
Results of the study: in female rats (fast acetylators of isoniazid), signs of the cytolytic mechanism of liver damage prevailed (more significant elevation of ALT activity, pronounced duration of thiopental sleep, pronounced hydropic degeneration of hepatocytes with the presence of hepatocyte necrosis, venous congestion and edema of the portal tracts). In males (with the phenotype of slow acetylation of isoniazid), a significant elevation of total and direct bilirubin levels, AST activity and, to a lesser extent, ALT were observed, i.e., signs of a mixed mechanism of liver damage (cholestatic and cytolytic).
About the Authors
G. N. MozhokinaRussian Federation
Galina N. Mozhokina, Doctor of Medical Sciences, Leading Researcher of Laboratory for Infectious Immunology, Pathology and Biotechnology
4, Dostoevsky St., Moscow, 127473
Phone: +7 (495) 688-41-85
А. V. Kazakov
Russian Federation
Aleksey V. Kazakov, Candidate of Medical Sciences, Senior Researcher of Children and Adolescent Tuberculosis Department
4, Dostoevsky St., Moscow, 127473
Yu. R. Zyuzya
Russian Federation
Yuliya R. Zyuzya, Candidate of Medical Sciences, Morbid Anatomist
4, Dostoevsky St., Moscow, 127473
L. Yu. Petrova
Russian Federation
Larisa Yu. Petrova, Candidate of Medical Sciences, Doctor of Clinical Laboratory Diagnostics Department
4, Dostoevsky St., Moscow, 127473
Phone: +7 (495) 681-08-72
References
1. Аyusheeva L.B. Polifitokhol – novy gepatoprotektor v klinike tuberkuleza. Avtoref. diss. kand. med. nauk. [Polyphytochole - a new hepatoprotector in the treatment of tuberculosis. Synopsis of Cand. Diss.]. Moscow, 1998. 21 p.
2. Vanyukov M.M. Issledovanie izmenchivosti atsetilyatornykh fenotipov krys. Avtoref. diss. kand. biol nauk. [Study of acetylizering phenotypes of rats. Synopsis of Cand. Diss.]. Moscow, 1984. 21 p.
3. Ivanova D.А., Borisov S.E. Profile and risk factors of adverse reactions in new tuberculosis cases receiving treatment. Tuberculosis and Lung Diseases, 2017, no. 6, pp. 46-52. (In Russ.)
4. Kazakov А.V., Mozhokina G.N., Аksenova V.А., Smerdin S.V., Popov S.А., Klevno N.I., Ragimov А.А., Kuznetsov O.E., Kozlov V.V. The impact of genetic polymorphism of the enzyme genes responsible for biotransformation of anti-tuberculosis drugs on the risk of hepatotoxic reactions in tuberculosis patients. Antibiotiki i Khimioterapiya, 2018, no. 5-6. (In Russ.) pp. 20-25. (In Russ.)
5. Misharina M.E., Tseylikman V.E., Tseylikman O.B., Lapshin M.S. et al. The content of lipid peroxidation products in the cerebral cortex in rats with different phenotypes of microsomal oxidation upon administration of an exogenous glucocorticoid. Elektronny Nauchny Journal Sovremennye Problemy Nauki I Obrazovaniya, 2013, no. 5. (In Russ.)
6. Starshinova А.А., Belyaeva E.N., Panteleev А.M., Pavlova M.V. Use of hepatoprotectors during tuberculosis chemotherapy: review of the Russian and international studies. Tuberculosis and Lung Diseases, 2018, vol. 96, no. 10, pp. 63-69. (In Russ.)
7. Sokolova G.B. Individualizirovannaya khimioterapiya tuberkuleza legkikh (eksperimentalno-klinicheskoe issledovanie). Dis. d. m. n. v vide nauchnogo doklada. [Personalized chemotherapy of pulmonary tuberculosis (an experimental clinical study). A presentation of Doct. Diss.]. Moscow, 2000.
Review
For citations:
Mozhokina G.N., Kazakov А.V., Zyuzya Yu.R., Petrova L.Yu. Parameters of hepatotoxic reactions caused by the combination of first line anti-tuberculosis drugs in rats with different acetylation phenotypes. Tuberculosis and Lung Diseases. 2020;98(7):51-55. (In Russ.) https://doi.org/10.21292/2075-1230-2020-98-7-51-55